BDRX (Biodexa Pharmaceuticals) Short Interest


BDRX Biodexa Pharmaceuticals PLC BDRX
45 GF Score
Price $2.54
GF Value $2.26
Valuation Modestly Overvalued
View Full Analysis

What is Biodexa Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BDRX vs CASIF, OGEN, ELOX: Short Interest Comparison

For the Biotechnology subindustry, Biodexa Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biodexa Pharmaceuticals Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biodexa Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Biodexa Pharmaceuticals's Short Interest falls into.


BDRX
45GF Score
Biodexa Pharmaceuticals PLC BDRX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biodexa Pharmaceuticals (BDRX) Overvalued in 2026?

Based on GuruFocus' analysis, Biodexa Pharmaceuticals stock appears to be overvalued. The current stock price of $2.54 is trading 12.4% above its estimated GF Value™ of $2.26. GuruFocus considers Biodexa Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for BDRX:

  • Short Interest:
  • GF Value™: $2.26 vs. price of $2.54 (12.4% above fair value)
  • GF Score™: 45/100

No single metric tells the full story. See the BDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biodexa Pharmaceuticals Business Description

Address 1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
45GF Score

Get the complete analysis for BDRX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.54
Price
$2.26
GF Value